Tag: gait deficit
Helius announces US FDA 510(k) submission for PoNS device label expansion...
Helius Medical Technologies has announced the filing of its US Food and Drug Administration (FDA) 510(k) submission for the Portable Neuromodulation Stimulator (PoNS) device’s...
Novel digital intervention meets primary endpoint in chronic stroke trial
MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was...
Neuromodulation device for treating MS-related gait deficit receives FDA authorisation
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...
